Fundraising Fox
/Companies
Sign in

Flare Therapeutics

7 known investors

Find your way into Flare Therapeutics

Sign up to see every warm intro you have to Flare Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Flare Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Flare Therapeutics develops small molecule medicines targeting transcription factors using a chemistry and proteomics platform that enables ligand discovery directly from cells. The company has lead programs in prostate cancer and advanced urothelial cancer, and maintains a partnership with Roche.

AI & Machine LearningBiotechDeep TechHealthtech

Founders & leadership

JAJim Audia
Jim AudiaExecutive Vice President, Drug Discovery and Early Development, and Founding Scientist
JSJacob Stuckey
Jacob StuckeySenior Director, Biochemistry and Chemical Biology, and Founding ScientistJacob Stuckey is a chemical biologist and founding scientist at Flare Therapeutics, where he serves as Senior Director of Biochemistry and Chemical Biology and focuses on small molecule medicine development.

Investors · 7

Pfizer Ventures✓ confirmed by Flare Therapeutics

How we know: the company's own site · Not right? Tell us

Third Rock Ventures✓ confirmed by Flare TherapeuticsBoston · $100K – $5M

How we know: the company's own site · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Nextech Investlisted by Nextech InvestZurich · $648K – $3.2M

How we know: Nextech Invest's portfolio page · a partner's Signal profile · open dataset · 5k.vc investor directory · Not right? Tell us

Pfizer Venture Investmentslisted by Pfizer Venture Investments$5M – $20M

How we know: Pfizer Venture Investments's portfolio page · the VCSheet dataset · Not right? Tell us

ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto

How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us

Agent CapitalreportedWaltham

How we know: the VCSheet dataset · Not right? Tell us

Funding

SEC filings, press & company announcements

$85M disclosed across 1 of 4 rounds · 2021–2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer - Flare Therapeutics | Flare Therapeuticsflaretx.com · Jun 2026Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officerglobenewswire.com · Jun 2026Flare Therapeutics Launches with $82 Million Series A Financing to Advance Precision Oncology Pipeline based on Novel Drug Discovery Approach for Transcription Factors - Flare Therapeutics | Flare Therapeuticsflaretx.com · May 2021

Frequently asked questions

What does Flare Therapeutics do?
Flare Therapeutics develops small molecule medicines targeting transcription factors using a chemistry and proteomics platform that enables ligand discovery directly from cells. The company has lead programs in prostate cancer and advanced urothelial cancer, and maintains a partnership with Roche.
Who founded Flare Therapeutics?
Flare Therapeutics was founded by Jim Audia, Jacob Stuckey.
Who are Flare Therapeutics's investors?
Flare Therapeutics's investors include NexTech Ventures, Pfizer Ventures, Third Rock Ventures, Nextech Invest, Pfizer Venture Investments, ShangBay Capital LLC, Agent Capital.
How much funding has Flare Therapeutics raised?
Flare Therapeutics has disclosed $85M raised across 1 of its 4 known rounds.